GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor.
CAT No: R1398
CAS No:91037-75-1
Synonyms/Alias:Grgdsp;H-Gly-Arg-Gly-Asp-Ser-Pro-OH;91037-75-1;GRGDSP TFA;Gly-arg-gly-asp-ser-pro;(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid;Glycyl-arginyl-glycyl-aspartyl-seryl-proline;MFCD00076460;CHEMBL6602;Glycyl-L-arginylglycyl-L-aspartyl-L-seryl-L-proline;SCHEMBL2790805;HY-P0290;NCGC00167214-01;DA-53978;FG110187;MS-30494;(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-5-guanidino-pentanoyl]amino]acetyl]amino]-4-hydroxy-4-oxo-butanoyl]amino]-3-hydroxy-propanoyl]pyrrolidine-2-carboxylic acid;
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More